NASDAQ
Channel Therapeutics Corporation (CHRO) has a free cash flow growth of 58.38% as of Friday, May 29, 2026. This represents a 106.57% increase compared to its 12-month average of -888.57%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.